News
$NeuroBo Pharmaceuticals (NRBO.US)$ Reuters· 1 min ago
NeuroBo Pharmaceuticals Announces Positive Top-Line Data From the Sad Part 1 of Its Phase 1 Clinical Trial Evaluating Da-1726 for the Treatment of Obesity
NeuroBo Pharmaceuticals Announces Positive Top-Line Data From the Sad Part 1 of Its Phase 1 Clinical Trial Evaluating Da-1726 for the Treatment of Obesity
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
